title: Noticeable decreased expression of tenascin-X in calcific aortic valves.
abstract: Calcification of aortic valves results in valvular aortic stenosis and is becoming a common valvular condition in elderly populations. An understanding of the molecular mechanisms of this valve lesion is important for revealing potential biomarkers associated with the development and progression of this disease. In order to identify proteins that are differentially expressed in calcific aortic valves (CAVs) compared with those in adjacent normal valvular tissues, comprehensive analysis of differentially expressed proteins in the tissues was done by a quantitative proteomic approach with isobaric tag for absolute and relative quantitation labeling followed by nanoliquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry. The proteomic analysis revealed 105 proteins differentially expressed in CAVs in contrast to adjacent normal valvular tissues with high confidence. Significantly increased expression (≥1.3-fold) was found in 34 proteins, whereas decreased expression (<0.77-fold) was found in 39 proteins in CAVs. Among them, α-2-HS-glycoprotein showed the greatest increase in expression (6.54-fold) and tenascin-X showed the greatest decrease in expression (0.37-fold). Numerous extracellular matrix proteins such as collagens were identified as proteins with significantly decreased expression. Panther pathway analysis showed that some of the identified proteins were linked to blood coagulation and integrin signaling pathways. Cluster analysis of the 105 proteins differentially expressed in CAVs based on the expression pattern revealed that tenascin-X was clustered with proteins controlling collagen structure and function, especially collagen fibrillogenesis, such as decorin and fibromodulin. We confirmed decreased levels of these proteins in CAVs by Western blot analyses. These results indicated that massive destruction of the extracellular matrix occurs in CAVs.
authors: Department of Biosignaling and Radioisotope Experiment, Center for Integrated Research in Science, Shimane University, Enya-cho, Izumo, Japan. matumoto@med.shimane-u.ac.jp
authors: Ken-Ichi
authors: K
authors: Matsumoto
authors: Kazumi
authors: K
authors: Satoh
authors: Tomoko
authors: T
authors: Maniwa
authors: Asuka
authors: A
authors: Araki
authors: Riruke
authors: R
authors: Maruyama
authors: Teiji
authors: T
authors: Oda
mesh_terms: D000368:Aged; D001021:Aortic Valve / Q000378:metabolism* / Q000473:pathology; D000082882:Bicuspid Aortic Valve Disease; D015536:Down-Regulation; D005109:Extracellular Matrix / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006330:Heart Defects, Congenital / Q000378:metabolism* / Q000473:pathology; D006349:Heart Valve Diseases / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008297:Male; D040901:Proteomics / Q000379:methods; D019063:Tenascin / Q000096:biosynthesis*; D061205:Vascular Calcification / Q000378:metabolism* / Q000473:pathology
chemical_list: D019063:Tenascin; C081865:tenascin X